In vitro chemosensitivity in breast cancer using ATP-tumor chemosensitivity assay

Archives of Pharmacal Research

Volumn 32, Issue 12, 2009, Pages 1737-1742

  Qi, Chun Jian ^a   Ning, Yong Ling ^a   Zhu, Yu Lan ^a   Min, Hai Yan ^a   Ye, Heng ^a   Qian, Ke Qing ^a  

^a THE AFFILIATED CHANGZHOU NO 2 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Chemosensitivity; Luciferase

Indexed keywords

ADENOSINE TRIPHOSPHATE; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; METHOTREXATE; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOPSY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CELL ASSAY; CELL HETEROGENEITY; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG SENSITIVITY; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; THORACOCENTESIS; TUMOR CELL;

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL LINE, TUMOR; DATA INTERPRETATION, STATISTICAL; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; LUCIFERASES;

EID: 77249179160     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-2211-0     Document Type: Article

References (19)

1. K. N. Bhalla 2003 Microtubule-targeted anticancer agents and apoptosis Oncogene 22 9075 9086 10.1038/sj.onc.1207233 1:CAS:528:DC%2BD3sXpsFOms78%3D 14663486 (Pubitemid 38121708)
2. E. Brown M. Markman 1996 Tumor chemosensitivity and chemoresistance assays Cancer 77 1020 1025 10.1002/(SICI)1097-0142(19960315)77:6<1020::AID- CNCR3>3.0.CO;2-L 1:STN:280:DyaK283jt1Cmsg%3D%3D 8635118 (Pubitemid 26080889)
3. J. M. Bull D. C. Tormey S. H. Li P. P. Carbone G. Falkson J. Blom E. Perlin R. Simon 1978 A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy Cancer 41 1649 1657 10.1002/1097-0142(197805)41:5<1649::AID-CNCR2820410501>3.0.CO;2-J 1:STN:280:DyaE1c7mslSlsA%3D%3D 348293 (Pubitemid 8335369)
4. A. U. Buzdar 2007 Preoperative chemotherapy treatment of breast cancer-a review Cancer 110 2394 2407 10.1002/cncr.23083 1:CAS:528:DC%2BD2sXhsVyisr7P 17941030 (Pubitemid 350174924)
5. T. C. Chou P. Talalay 1984 Quantitative analysis of doseeffect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv. Enzyme Regul. 22 27 55 10.1016/0065-2571(84)90007-4 1:CAS:528:DyaL2cXktlaksLk%3D 6382953
6. F. Di Nicolantonio L. A. Knight S. Di Palma S. Sharma P. A. Whitehouse S. J. Mercer P. A. Charlton D. Norris I. A. Cree 2004 Ex vivo characterization of XR11576 (MLN576) against ovarian cancer and other solid tumors Anticancer Drugs 15 849 860 10.1097/00001813-200410000-00005 15457125 (Pubitemid 39482925)
7. M. Doerler J. Hyun I. Venten A. Potthoff U. Bartke K. Serova S. Hoextermann P. Altmeyer N. H. Brockmeyer 2007 Does chemosensitivity-assay- directed therapy have an influence on the prognosis of patients with malignant melanoma stage IV? A retrospective study of 14 patients with malignant melanoma stage IV Eur. J. Med. Res. 12 497 502 1:CAS:528:DC%2BD1cXjs1Chug%3D%3D 18024256
8. D. A. Gewirtz 2000 Growth arrest and cell death in the breast tumor cell in response to ionizing radiation and chemotherapeutic agents which induce DNA damage Breast Cancer Res. Treat. 62 223 235 10.1023/A:1006414422919 1:CAS:528:DC%2BD3cXnvV2qur0%3D 11072787 (Pubitemid 30804444)
9. G. Konecny C. Crohns M. Pegram M. Felber S. Lude C. Kurbacher I. A. Cree H. Hepp M. Untch 2000 Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer Gynecol. Oncol. 77 258 263 10.1006/gyno.2000.5728 1:CAS:528:DC%2BD3cXislCntL8%3D 10785475 (Pubitemid 30317146)
10. G. Konecny M. Untch D. Slamon M. Beryt S. Kahlert M. Felber E. Langer S. Lude H. Hepp M. Pegram 2001 Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples Breast Cancer Res. Treat. 67 223 233 10.1023/A:1017980411398 1:CAS:528:DC%2BD3MXntFGlt7o%3D 11561768 (Pubitemid 32803528)
11. C. M. Kurbacher H. W. Bruckner I. A. Cree J. A. Kurbacher L. Wilhelm G. Poch D. Indefrei P. Mallmann P. E. Andreotti 1997 Mitoxantrone combined with paclitaxel as salvage therapy for platinum-refractory ovarian cancer: laboratory study and clinical pilot trial Clin. Cancer Res. 3 1527 1533 1:CAS:528:DyaK2sXmt1yhtrY%3D 9815839
12. C. M. Kurbacher I. A. Cree 2005 Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements Methods Mol. Med. 110 101 120 1:CAS:528:DC%2BD2MXktF2juro%3D 15901931
13. C. M. Kurbacher I. A. Cree H. W. Bruckner U. Brenne J. A. Kurbacher K. Muller T. Ackermann T. J. Gilster L. M. Wilhelm H. Engel 1998 Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer Anticancer Drugs 9 51 57 10.1097/00001813-199801000-00006 1:CAS:528: DyaK1cXotVymug%3D%3D 9491792 (Pubitemid 28088179)
14. H. L. McArthur C. A. Hudis 2008 Advances in adjuvant chemotherapy of early stage breast cancer Cancer Treat Res. 141 37 53 10.1007/978-0-387-73161-2- 18274081
15. S. J. Mercer S. S. Somers L. A. Knight P. A. Whitehouse S. Sharma F. Di Nicolantonio S. Glaysher S. Toh I. A. Cree 2003 Heterogeneity of chemosensitivity of esophageal and gastric carcinoma Anticancer Drugs 14 397 403 10.1097/00001813-200307000-00002 1:CAS:528:DC%2BD3sXlsVehsbk%3D 12853879 (Pubitemid 36951788)
16. C. W. Michalski M. Erkan D. Sauliunaite T. Giese R. Stratmann C. Sartori N. A. Giese H. Friess J. Kleeff 2008 Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer Br. J. Cancer 99 760 767 10.1038/sj.bjc.6604528 1:CAS:528:DC%2BD1cXhtVGgtb7O 18728667
17. Piccart-Gebhart, M. J. and Sotiriou, C., Adjuvant chemotherapy-yes or no? Prognostic markers in early breast cancer. Ann Oncol (2007).
18. P. A. Whitehouse L. A. Knight F. Di Nicolantonio S. J. Mercer S. Sharma I. A. Cree 2003 Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA) Anticancer Drugs 14 369 375 10.1097/00001813-200306000-00008 1:CAS:528:DC%2BD3sXktlOitrk%3D 12782944 (Pubitemid 36683749)
19. P. A. Whitehouse S. J. Mercer L. A. Knight F. Di Nicolantonio A. O'Callaghan I. A. Cree 2003 Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C Br. J Cancer 89 2299 2304 10.1038/sj.bjc.6601403 1:CAS:528:DC%2BD3sXpvVShtbk%3D 14676810 (Pubitemid 38168015)